Drug Type Small molecule drug |
Synonyms X-165 |
Target |
Action inhibitors |
Mechanism autotaxin inhibitors(Ectonucleotide pyrophosphatase/phosphodiesterase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H28F4N6O4 |
InChIKeyCDSKRHGFXHZEQL-JOCHJYFZSA-N |
CAS Registry1815589-34-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Preclinical | United States | 24 Jan 2019 | |
Fibrosis | Preclinical | United States | - |